GSK submits NDA for reformulated Coreg

GlaxoSmithKline (LSE:GSK; GSK) submitted an NDA for a controlled-released formulation of its Coreg carvedilol beta blocker that was developed using Micropump technology from Flamel (FLML). Coreg is ma...